Clinical trial
Necessity and Effectiveness of Empirical Antibiotic Use in Mild to Moderate Acute Inflammatory Gallbladder Disease; a Multicenter, Double-blind, Randomized, Placebo-controlled Trial
NCT05339282 is registered in ClinicalTrials.gov with Seoul St. Mary's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Necessity and Effectiveness of Empirical Antibiotic Use in Mild to Moderate Acute Inflammatory Gallbladder Disease; a Multicenter, Double-blind, Randomized, Placebo-controlled Trial
- Lead sponsor
- Seoul St. Mary's Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2022
- Completion date
- April 30, 2024
- Enrollment
- 370 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.